# Oncimmune

**Canonical:** https://apis.io/providers/oncimmune/  
**Website:** https://www.oncimmune.com/  
**APIs profiled:** 0

Oncimmune is a biotechnology company specializing in antibody and autoantibody biomarker discovery for precision medicine. Its proprietary ImmunoINSIGHTS platform screens against 9,000+ human antigens using Luminex xMAP bead-based multiplexed immunoassay technology, minimal sample volumes, high-throughput automated robotic workflows, and proprietary machine-learning algorithms to identify immune-system signatures across immuno-oncology, autoimmune disease, and infectious disease. Products include the ImmunoINSIGHTS 2K targeted panels, custom biomarker discovery services, and bioinformatics/data-science multiomics integration. Oncimmune was acquired by Alden Scientific in July 2025. The company operates as a research and discovery services provider and does not publish a public developer or API platform.

## Kin Score — 8.9 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 8.9).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 10.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotechnology, Precision Medicine, Biomarker Discovery, Immuno-Oncology, Autoantibody, Diagnostics, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/oncimmune/). Scores are computed from the provider's own public artifacts under a published rubric.